Cortechs.ai | Understanding Intracranial Volume (ICV) Analysis in Cortechs.ai’ Quantitative Imaging Products

Understanding Intracranial Volume (ICV) Analysis in Cortechs.ai’ Quantitative Imaging Products

The ability to compare the volumes of patients’ brain structures to brain structure volumes of healthy controls is a powerful tool to help physicians assess possible existence of neurodegeneration or the progression of a neurodegenerative disorder.

To adjust for any variation in brain size, sex difference, and inter-individual head-size in a population, brain structure volumes are normalized (or scaled) to a common measurement.

Cortechs.ai’ quantitative imaging software uses Intracranial Volume (ICV) to normalize an individual’s brain structure volumes, and automatically calculates it during the post-processing of brain MRIs for volumetric analysis. This consistent measure gives clinicians additional context of their patient’s brain structure volumes, regardless of head size.

ICV, also known as TIV (Total Intracranial Volume), is the volume of the cranial cavity as taken from a 3D T1 MRI, as outlined by the supratentorial dura matter, or cerebral contour when dura is not clearly detectable.

Cortechs.ai | Understanding Intracranial Volume (ICV) Analysis in Cortechs.ai’ Quantitative Imaging Products
Example of segmentation with intracranial mask from T1-weighted image. Image credit: Malone, I.B. et al. (2015). Accurate Automatic Estimation of Total Intracranial Volume: A Nuisance Variable with Less Nuisance. NeuroImage 104 (366-372).

ICV is a very consistent measure across the lifespan of a patient, making it a reliable tool for correction of head size variation across individuals. This correction is especially helpful when assessing neurodegenerative conditions.

For example, Patient A and Patient B both have thalamic volumes that are consistent with the average for their age and sex-matched population. Patient A is 5’6” tall, with an average head circumference, while Patient B is 6’2” tall with an above average head circumference. If the thalamic volumes could be interpreted without correcting for ICV, both patients would yield a normal result. However, once the patient’s thalamic volumes are normalized to their individual ICV, it could become apparent that Patient B’s thalamic volume is lower than expected for their age and gender.

NeuroQuant reports provide brain structure volumes (relevant to the report), % ICV and normative percentiles. NeuroQuant automatically calculates the ICV to accurately compare an individual’s brain structure volumes to Cortechs.ai’ age and sex-matched normative reference data. The ICV normalization and reference comparison on NeuroQuant reports provide physicians with a framework to better understand brain structure volumes when assessing patients.

Cortechs.ai | Understanding Intracranial Volume (ICV) Analysis in Cortechs.ai’ Quantitative Imaging Products

Need more information about ICV or Cortechs.ai quantitative image products? Contact us.

 

More Resources

12/18/2025

Reimbursement Essentials for Quantitative Imaging: Key Takeaways From Our Expert Webinar

Our reimbursement webinar walked through best practices for billing, coding, and securing payment for NeuroQuant and OnQ Prostate, helping inform providers.

12/15/2025

OnQ Prostate for Radiation Oncology

OnQ Prostate is at the forefront of advanced imaging to empower the delivery of true precision therapies.

12/10/2025

Reflections on RSNA 2025 and What We Learned at the Cortechs.ai Booth 

If there was one overall takeaway from RSNA 2025, it’s that clinicians are ready for tools that reduce manual work and make reporting more consistent.

12/09/2025

Dementia Imaging: Case-based PET/MRI Approach

Join us for a webinar that will unlock the latest insights in dementia imaging with Dr. Ana M. Franceschi, MD PhD.

12/09/2025

SNO 2025 Recap: Collaboration Driving Innovation in Neuro-Oncology

The 2025 Society for Neuro-Oncology meeting was more than a conference, it was a hub of collaboration and conversation among industry leaders and physicians.

11/19/2025

Philips and Cortechs.ai extend partnership to advance quantitative neuroimaging and strengthen Philips’ leadership in precision diagnostics in neurology

The companies will integrate Cortechs.ai’s advanced AI-enabled neuroimaging analytics directly into Philips’ MR systems.
Scroll to Top